Bernard Gilly

Bernard Gilly is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as CEO of BrainEver since September 2015 and as Chairman of iBionext, Bernard has previously held leadership roles including CEO of GenSight Biologics until January 2024, CEO of Fovea Pharmaceuticals/Sanofi from 2005 to 2012, and Partner at Sofinnova Partners between 2000 and 2005. Early in Bernard's career, executive positions included CEO of Transgene from 1992 to 2000 and VP of R&D at PMC/Sanofi Pasteur from 1987 to 1994.